Australian Biotherapeutics begins production at new factory
Australian Biotherapeutics has begun production at a new $10.4 million factory at Coolum’s Suncoast Business Park.
Australian Biotherapeutics has begun production at a new $10.4 million factory at Coolum’s Suncoast Business Park.
Electronic warfare group DEWC Systems and rocket manufacturer Gilmour Space Technologies are to collaborate to build prototype satellites equipped with electronic warfare payloads.
Research and market development of value-added metals is bearing fruit with Lepidico and Australian Vanadium (AVL) both reporting new company milestones. Today resources and chemicals group Australian Vanadium confirmed positive results from its Cooperative Research Centre CRC-P grant studying the production of value-added vanadium chemicals. Also today lithium chemicals company Lepidico announced it was negotiating…
In May 1926, the Australian inventor of the Sunshine Harvester, Hugh McKay, died. His homegrown invention had created the largest factory in Australia at the time, peaking at 3,000 workers, and transformed Australian agriculture.
Monash University researchers have developed an apple-picking robot that displayed a better than 85 per cent success rate in field trials over February and March at Fankhauser Apples in Drouin, Victoria.
Mohammad Alhawamdeh, Omar Alajarmeh, Tristan Shelley, Xuesen Zeng, Peter Schubel explain pultrusion, its usefulness and its growth in adoption in this installment of our Fibres and composites transforming industry series.
Swinburne University of Technology and Sutton Tools have established a joint Smart Manufacturing Centre to work on projects in advanced manufacturing over the next five years in a model for industry/SME collaboration. A research agreement establishing the new centre, which will be based at Sutton Tools in Thomastown, Victoria, was signed by Swinburne’s Deputy Vice-Chancellor,…
Pharmaceutical developer Starpharma has reported its strong financial position and progress on numerous R&D fronts over the March quarter as it accelerates research and commercialisation of its drug portfolio. The Melbourne company spent $4.3 million on R&D in the quarter as well as manufacturing expenses, ending with a closing cash balance of $64.3 million. Net…
Molecular diagnostic company Genetic Signatures has reported year to date sales of $23 million for the nine months to March 31, more than double its full year revenue in the previous financial year. Third quarter sales were $4.3 million including instrument sales of $300,000, up 136 per cent on the previous corresponding period. The company…